NAD+ Nasal Spray: Does It Actually Work?

Written by the Nuvirox Research Team

Short answer: NAD+ nasal spray is marketed on the promise of bypassing digestion for faster, higher absorption, but no published human study has actually measured whether that’s true. If you’re comparing nasal spray to an oral NAD+ precursor supplement, the fair comparison is between something with real safety and pharmacokinetic data behind it and something that currently has none.

Before going further: NAD+ Restore is an oral nicotinamide riboside (NR) capsule, not a nasal spray, and the oral-route human data below applies to precursor supplementation generally, not to nasal delivery of any form.

What is NAD+ nasal spray supposed to do?

The pitch behind NAD+ nasal spray is straightforward: swallowed supplements have to survive stomach acid and pass through the liver before reaching the bloodstream (first-pass metabolism), which reduces how much of the active ingredient actually reaches your cells. Nasal delivery, the theory goes, lets the compound absorb directly through nasal mucous membranes into circulation, skipping that loss.

That first-pass metabolism logic is real pharmacology, and it does apply to many drugs delivered nasally (certain hormones, some pain medications). The open question specific to NAD+ is whether the actual molecule, or the precursor in the spray, crosses the nasal mucosa efficiently enough to matter — and that hasn’t been measured.

What does 'no published data' actually mean here?

We searched specifically for clinical pharmacokinetic studies of intranasal NAD+ or NR — the kind of trial that would draw blood at multiple time points after a dose and measure how much of the compound actually shows up in circulation. We found none. The bioavailability percentages you’ll see quoted on nasal spray product sites and blogs (commonly 15–25%) do not link back to a specific clinical trial in any source we could verify; they appear to be estimates or extrapolations, not measured results.

What human studies actually show

What has been measured: oral NR pharmacokinetics. An 8-week randomized trial found that oral NR doses of 100, 300, and 1000 mg dose-dependently raised whole-blood NAD+ by 22%, 51%, and 142% respectively within two weeks, with no increase in adverse events across doses (Conze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Sci Rep. 2019;9:9772. doi:10.1038/s41598-019-46120-z). A separate 6-week crossover trial in older adults confirmed oral NR is well tolerated and reliably raises NAD+ metabolites (Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286. doi:10.1038/s41467-018-03421-7). This is real, measured, published pharmacokinetic and safety data — for the oral route.

What has not been measured: nasal NAD+ pharmacokinetics. No peer-reviewed, PubMed-indexed human pharmacokinetic or efficacy trials of intranasal NAD+ or NR delivery were identified as of this writing; available oral-route pharmacokinetic data (Conze 2019; Martens 2018) cannot be extrapolated to the nasal route. Consumer-facing reviews of NAD+ patches (a related transdermal delivery format) explicitly note the same gap for skin delivery, and the same absence of trial data generally applies to nasal delivery (Bolt Pharmacy. Do NAD Patches Work? Evidence and Safety Review. Consumer-facing evidence summary noting absence of published transdermal NAD+ pharmacokinetic or efficacy trials in humans (2026).).

A relevant general principle. NAD+ itself is a relatively large, charged molecule (molecular weight around 663 daltons), which is one reason oral NAD+ precursor supplements use smaller molecules like nicotinamide riboside rather than NAD+ itself — smaller molecules cross cell membranes and the gut wall more efficiently. Whether that same size and charge issue limits nasal mucosal absorption for NAD+ or its precursors hasn’t been directly tested, but it’s a reasonable question the marketing materials don’t address.

What NAD+ Restore won't do

NAD+ Restore is an oral capsule, not a nasal spray, so a direct absorption comparison between the two products isn’t possible using published data. This article isn’t a claim that oral is proven superior to nasal in a head-to-head trial — no such trial exists either. What we can say is that the oral NR route has real human pharmacokinetic and safety data behind it, and nasal NAD+ delivery currently does not.

See a doctor before starting any new nasal product if you have chronic sinus issues, nasal polyps, or are prone to nosebleeds, since nasal spray formulations (regardless of active ingredient) can cause local irritation in sensitive users.

Dosing and realistic timelines

Because there’s no clinical trial establishing an effective nasal NAD+ dose, we can’t responsibly recommend one. For oral NR, human trials support 300–1000 mg daily as both safe and effective for raising blood NAD+ (Conze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Sci Rep. 2019;9:9772. doi:10.1038/s41598-019-46120-z); NAD+ Restore provides 500 mg NR per 2-capsule serving, in the middle of that studied range, alongside 150 mg trans-resveratrol and 50 mg quercetin.

Frequently asked questions

Is NAD+ nasal spray FDA approved?

No NAD+ nasal spray product is FDA-approved as a drug; these are sold as dietary supplements or, in some cases, through compounding pharmacies, which is a different regulatory category with less rigorous efficacy review.

Why do nasal spray sellers cite 15–25% bioavailability?

We couldn’t trace this figure to a specific published pharmacokinetic study; it appears in marketing materials without a clear primary source, which is a reasonable thing to ask about before paying a premium for the delivery format.

Is oral NR actually well absorbed?

Yes — published trials measuring blood NAD+ after oral NR dosing show clear, dose-dependent increases, which is more than can currently be said for nasal delivery of any NAD+ form.

Does nasal delivery work better for other compounds?

Yes, for some — certain hormones and medications do show genuine bioavailability advantages via the nasal route in published pharmacokinetic studies. That established principle for other drugs doesn’t automatically transfer to NAD+ without its own dedicated study.

From Nuvirox

Why we formulated NAD+ Restore

Each 2-capsule serving delivers 500 mg nicotinamide riboside chloride (NR) — one of the two most-researched NAD+ precursors, within the dose range used in published human trials — alongside 150 mg trans-resveratrol and 50 mg quercetin, polyphenols studied alongside NAD+ pathways for cellular health support, plus 10 mg fenugreek-derived galactomannans to support absorption.

Backed by a 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should.

Learn more about NAD+ Restore →

The bottom line

The idea behind NAD+ nasal spray isn’t absurd — avoiding first-pass metabolism is a legitimate pharmacological consideration for some compounds. But 'plausible mechanism' and 'measured result' are different things, and right now, nasal NAD+ delivery only has the former. If you want a delivery route with actual human blood-level data behind it, oral nicotinamide riboside currently has more of it.

References

1. Conze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Sci Rep. 2019;9:9772. doi:10.1038/s41598-019-46120-z
2. Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286. doi:10.1038/s41467-018-03421-7
3. Bolt Pharmacy. Do NAD Patches Work? Evidence and Safety Review. Consumer-facing evidence summary noting absence of published transdermal NAD+ pharmacokinetic or efficacy trials in humans (2026).

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.